000919 金陵药业
已收盘 09-18 15:00:00
资讯
新帖
简况
金陵药业：截至2026年9月10日，公司股东人数为39,042
证券之星 · 09-15
金陵药业：截至2026年9月10日，公司股东人数为39,042
金陵药业：截至2026年8月31日，公司股东人数为40,300
证券之星 · 09-08
金陵药业：截至2026年8月31日，公司股东人数为40,300
股市必读：金陵药业新发布《关于更换持续督导保荐代表人的公告》
证券之星 · 09-04
股市必读：金陵药业新发布《关于更换持续督导保荐代表人的公告》
金陵药业：公司已于2026年4月14日披露《关于公司递交〈投资意向函〉的公告》（2026‑021）
证券之星 · 09-03
金陵药业：公司已于2026年4月14日披露《关于公司递交〈投资意向函〉的公告》（2026‑021）
金陵药业（000919）披露更换持续督导保荐代表人公告，9月2日股价下跌2.33%
证券之星 · 09-02
金陵药业（000919）披露更换持续督导保荐代表人公告，9月2日股价下跌2.33%
金陵药业（000919）2026年中报简析：净利润同比增长4.24%，盈利能力上升
证券之星 · 08-30
金陵药业（000919）2026年中报简析：净利润同比增长4.24%，盈利能力上升
金陵药业(000919)8月20日股东户数4.27万户，较上期增加5.24%
证券之星 · 08-29
金陵药业(000919)8月20日股东户数4.27万户，较上期增加5.24%
金陵药业(000919.SZ)发布半年度业绩，归母净利润5038.25万元，同比增长4.24%
智通财经 · 08-28
金陵药业(000919.SZ)发布半年度业绩，归母净利润5038.25万元，同比增长4.24%
金陵药业(000919)8月20日股东户数4.27万户，较上期增加5.24%
证券之星 · 08-27
金陵药业(000919)8月20日股东户数4.27万户，较上期增加5.24%
金陵药业(000919)8月10日股东户数4.06万户，较上期增加0.05%
证券之星 · 08-18
金陵药业(000919)8月10日股东户数4.06万户，较上期增加0.05%
金陵药业：截至2026年8月10日，公司股东人数为40,565
证券之星 · 08-18
金陵药业：截至2026年8月10日，公司股东人数为40,565
金陵药业(000919)7月31日股东户数4.05万户，较上期减少2.92%
证券之星 · 08-11
金陵药业(000919)7月31日股东户数4.05万户，较上期减少2.92%
金陵药业：截至2026年7月31日，公司股东人数为40,543
证券之星 · 08-11
金陵药业：截至2026年7月31日，公司股东人数为40,543
金陵药业(000919)7月31日股东户数4.05万户，较上期减少2.92%
证券之星 · 08-05
金陵药业(000919)7月31日股东户数4.05万户，较上期减少2.92%
金陵药业：截至2026年7月31日，公司股东人数为40,543
证券之星 · 08-05
金陵药业：截至2026年7月31日，公司股东人数为40,543
金陵药业（000919）披露羧基麦芽糖铁注射液上市许可申请获受理的公告，7月31日股价上涨1.62%
证券之星 · 07-31
金陵药业（000919）披露羧基麦芽糖铁注射液上市许可申请获受理的公告，7月31日股价上涨1.62%
股市必读：金陵药业（000919）7月27日董秘有最新回复
证券之星 · 07-28
股市必读：金陵药业（000919）7月27日董秘有最新回复
金陵药业(000919)7月20日股东户数4.18万户，较上期增加3.1%
证券之星 · 07-23
金陵药业(000919)7月20日股东户数4.18万户，较上期增加3.1%
金陵药业：截至2026年7月20日，公司股东人数为41,764
证券之星 · 07-23
金陵药业：截至2026年7月20日，公司股东人数为41,764
股市必读：金陵药业（000919）7月20日董秘有最新回复
证券之星 · 07-21
股市必读：金陵药业（000919）7月20日董秘有最新回复
加载更多
公司概况
公司名称：
金陵药业股份有限公司
所属行业：
医药制造业
上市日期：
1999-11-18
主营业务：
金陵药业股份有限公司的主营业务是药品与医疗器械制造、医康养护服务。公司的主要产品是脉络宁注射液、脉络宁口服液、琥珀酸亚铁片、琥珀酸亚铁缓释片、香菇多糖注射液、吸收性明胶海绵、医疗服务、康养护服务。
发行价格：
8.40
{"stockData":{"symbol":"000919","market":"SZ","secType":"STK","nameCN":"金陵药业","latestPrice":6.46,"timestamp":1789715010000,"preClose":6.47,"halted":0,"volume":8582500,"delay":0,"changeRate":-0.0015,"floatShares":622000000,"shares":622000000,"eps":0.09,"marketStatus":"已收盘","change":-0.01,"latestTime":"09-18 15:00:00","open":6.43,"high":6.58,"low":6.42,"amount":55805100,"amplitude":0.0247,"askPrice":6.46,"askSize":88,"bidPrice":6.45,"bidSize":1126,"shortable":0,"etf":0,"ttmEps":0.09,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789954200000},"marketStatusCode":5,"adr":0,"adjPreClose":6.47,"symbolType":"stock","openAndCloseTimeList":[[1789695000000,1789702200000],[1789707600000,1789714800000]],"highLimit":7.12,"lowLimit":5.82,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":621924528,"isCdr":false,"pbRate":1.07,"roa":"--","peRate":71.777778,"roe":"1.33%","epsLYR":0.0867,"committee":0.201928,"marketValue":4018000000,"turnoverRate":0.0138,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-09-21。","floatMarketCap":4016000000},"requestUrl":"/m/hq/s/000919","defaultTab":"news","newsList":[{"id":"2667961209","title":"金陵药业：截至2026年9月10日，公司股东人数为39,042","url":"https://stock-news.laohu8.com/highlight/detail?id=2667961209","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667961209?lang=zh_cn&edition=full","pubTime":"2026-09-15 15:39","pubTimestamp":1789457947,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)09月15日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司截止9月10日最新股东数是多少？谢谢金陵药业回复：投资者，您好！截至2026年9月10日，公司股东人数为39,042，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500020122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000919","BK0028","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665344590","title":"金陵药业：截至2026年8月31日，公司股东人数为40,300","url":"https://stock-news.laohu8.com/highlight/detail?id=2665344590","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665344590?lang=zh_cn&edition=full","pubTime":"2026-09-08 11:33","pubTimestamp":1788838386,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)09月08日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止至2026年8月31日股东人数是多少谢谢金陵药业回复：投资者，您好！截至2026年8月31日，公司股东人数为40,300，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800015094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0096","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664057898","title":"股市必读：金陵药业新发布《关于更换持续督导保荐代表人的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664057898","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664057898?lang=zh_cn&edition=full","pubTime":"2026-09-04 01:25","pubTimestamp":1788456312,"startTime":"0","endTime":"0","summary":"公司公告汇总关于更换持续督导保荐代表人的公告金陵药业股份有限公司于2026年9月2日发布公告，因原持续督导保荐代表人王昭辉先生工作变动，中信证券委派邵寅翀先生接替其职务。公司2023年度向特定对象发行A股股票项目的持续督导期虽已于2025年12月31日届满，但因募集资金尚未使用完毕，中信证券将继续履行持续督导义务至募集资金全部使用完毕为止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400001977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0096","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664470008","title":"金陵药业：公司已于2026年4月14日披露《关于公司递交〈投资意向函〉的公告》（2026‑021）","url":"https://stock-news.laohu8.com/highlight/detail?id=2664470008","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664470008?lang=zh_cn&edition=full","pubTime":"2026-09-03 08:49","pubTimestamp":1788396546,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)09月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司外延并购有没有进展金陵药业回复：投资者，您好，感谢您对公司的关注。公司已于 2026 年 4 月 14日披露《关于公司递交〈投资意向函〉的公告》（2026‑021），该事项目前仍处于意向阶段。后续若出现达到披露标准的实质性进展或重大变化，公司将及时履行信息披露义务，敬请注意投资风险，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300007836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0096","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664172738","title":"金陵药业（000919）披露更换持续督导保荐代表人公告，9月2日股价下跌2.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664172738","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664172738?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:25","pubTimestamp":1788359121,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，金陵药业报收于6.7元，较前一交易日下跌2.33%，最新总市值为41.67亿元。近日，金陵药业股份有限公司发布公告称，因原持续督导保荐代表人王昭辉先生工作变动，中信证券委派邵寅翀先生接替其职务。公司2023年度向特定对象发行A股股票项目的持续督导期虽已于2025年12月31日届满，但因募集资金尚未使用完毕，中信证券将继续履行持续督导义务至募集资金全部使用完毕为止。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200042975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000919","BK0096","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663704825","title":"金陵药业（000919）2026年中报简析：净利润同比增长4.24%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2663704825","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663704825?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:21","pubTimestamp":1788042105,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期金陵药业发布2026年中报。截至本报告期末，公司营业总收入15.84亿元，同比下降1.04%，归母净利润5038.25万元，同比上升4.24%。按单季度数据看，第二季度营业总收入8.16亿元，同比上升3.12%，第二季度归母净利润2237.93万元，同比下降11.72%。本报告期金陵药业盈利能力上升，毛利率同比增幅15.14%，净利率同比增幅12.2%。去年的净利率为1.6%，算上全部成本后，公司产品或服务的附加值不高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000002607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663012640","title":"金陵药业(000919)8月20日股东户数4.27万户，较上期增加5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663012640","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663012640?lang=zh_cn&edition=full","pubTime":"2026-08-29 17:12","pubTimestamp":1787994774,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金陵药业披露，截至2026年8月20日公司股东户数为4.27万户，较8月10日增加2124.0户，增幅为5.24%。在化学制药行业个股中，金陵药业股东户数高于行业平均水平，截至8月20日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年8月10日至2026年8月20日，金陵药业区间涨幅为7.14%，在此期间股东户数增加2124.0户，增幅为5.24%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900023447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","000919","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662009669","title":"金陵药业(000919.SZ)发布半年度业绩，归母净利润5038.25万元，同比增长4.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662009669","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662009669?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:47","pubTimestamp":1787924835,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金陵药业 发布2026年半年度报告，报告期内，公司实现营业收入15.84亿元，同比下降1.04%;归属于上市公司股东的净利润5038.25万元，同比增长4.24%;归属于上市公司股东的扣除非经常性损益的净利润4891.28万元，同比增长37.74%;基本每股收益0.081元。报告期内，公司“医药工业和医康养护”双平台同步攻坚、协同发力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703543","title":"金陵药业(000919)8月20日股东户数4.27万户，较上期增加5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703543","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662703543?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:04","pubTimestamp":1787825097,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金陵药业披露，截至2026年8月20日公司股东户数为4.27万户，较8月10日增加2124.0户，增幅为5.24%。在化学制药行业个股中，金陵药业股东户数高于行业平均水平，截至8月20日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年8月10日至2026年8月20日，金陵药业区间涨幅为7.14%，在此期间股东户数增加2124.0户，增幅为5.24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700043018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000919","BK0096","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660465193","title":"金陵药业(000919)8月10日股东户数4.06万户，较上期增加0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660465193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660465193?lang=zh_cn&edition=full","pubTime":"2026-08-18 17:28","pubTimestamp":1787045300,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金陵药业披露，截至2026年8月10日公司股东户数为4.06万户，较7月31日增加22.0户，增幅为0.05%。在化学制药行业个股中，金陵药业股东户数高于行业平均水平，截至8月10日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年7月31日至2026年8月10日，金陵药业区间涨幅为4.61%，在此期间股东户数增加22.0户，增幅为0.05%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800030541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","000919","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660409459","title":"金陵药业：截至2026年8月10日，公司股东人数为40,565","url":"https://stock-news.laohu8.com/highlight/detail?id=2660409459","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660409459?lang=zh_cn&edition=full","pubTime":"2026-08-18 11:33","pubTimestamp":1787023990,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)08月18日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问截止8月10号，公司的股东人数是多少？谢谢金陵药业回复：投资者，您好！截至2026年8月10日，公司股东人数为40,565，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800016043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0096","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658964319","title":"金陵药业(000919)7月31日股东户数4.05万户，较上期减少2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658964319","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658964319?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:29","pubTimestamp":1786440551,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金陵药业披露，截至2026年7月31日公司股东户数为4.05万户，较7月20日减少1221.0户，减幅为2.92%。在化学制药行业个股中，金陵药业股东户数高于行业平均水平，截至7月31日，化学制药行业平均股东户数为3.59万户。从股价来看，2026年7月20日至2026年7月31日，金陵药业区间涨幅为0.32%，在此期间股东户数减少1221.0户，减幅为2.92%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100027988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","000919","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658967097","title":"金陵药业：截至2026年7月31日，公司股东人数为40,543","url":"https://stock-news.laohu8.com/highlight/detail?id=2658967097","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658967097?lang=zh_cn&edition=full","pubTime":"2026-08-11 15:07","pubTimestamp":1786432035,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)08月11日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好!请问截止7月31号，公司的股东人数是多少?谢谢！金陵药业回复：投资者，您好！截至2026年7月31日，公司股东人数为40,543，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100018907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","000919","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657517205","title":"金陵药业(000919)7月31日股东户数4.05万户，较上期减少2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657517205","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657517205?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:43","pubTimestamp":1785923018,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金陵药业披露，截至2026年7月31日公司股东户数为4.05万户，较7月20日减少1221.0户，减幅为2.92%。在化学制药行业个股中，金陵药业股东户数高于行业平均水平，截至7月31日，化学制药行业平均股东户数为3.59万户。从股价来看，2026年7月20日至2026年7月31日，金陵药业区间涨幅为0.32%，在此期间股东户数减少1221.0户，减幅为2.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500032412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000919","BK0096","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657534516","title":"金陵药业：截至2026年7月31日，公司股东人数为40,543","url":"https://stock-news.laohu8.com/highlight/detail?id=2657534516","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657534516?lang=zh_cn&edition=full","pubTime":"2026-08-05 15:06","pubTimestamp":1785913582,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)08月05日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截至7月30日公司股东人数是多少？金陵药业回复：投资者，您好！截至2026年7月31日，公司股东人数为40,543，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500022844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0096","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655362714","title":"金陵药业（000919）披露羧基麦芽糖铁注射液上市许可申请获受理的公告，7月31日股价上涨1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655362714","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655362714?lang=zh_cn&edition=full","pubTime":"2026-07-31 22:27","pubTimestamp":1785508041,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，金陵药业报收于6.29元，较前一交易日上涨1.62%，最新总市值为39.12亿元。该股当日开盘6.19元，最高6.29元，最低6.17元，成交额达6145.37万元，换手率为1.58%。近日，金陵药业股份有限公司福州梅峰制药厂提交的羧基麦芽糖铁注射液药品注册上市许可申请已获国家药品监督管理局受理。该产品为第三代静脉铁剂，用于治疗缺铁性贫血，目前国内仅有原研进口产品上市，尚无仿制药获批。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100042141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000919","BK0096","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654447660","title":"股市必读：金陵药业（000919）7月27日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2654447660","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654447660?lang=zh_cn&edition=full","pubTime":"2026-07-28 01:17","pubTimestamp":1785172629,"startTime":"0","endTime":"0","summary":"截至2026年7月27日收盘，金陵药业报收于6.15元，上涨2.33%，换手率1.68%，成交量10.44万手，成交额6390.33万元。交易信息汇总资金流向7月27日主力资金净流出282.8万元，占总成交额0.0%；游资资金净流出140.33万元，占总成交额0.0%；散户资金净流入423.13万元，占总成交额0.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800000700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0096","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653745530","title":"金陵药业(000919)7月20日股东户数4.18万户，较上期增加3.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653745530","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653745530?lang=zh_cn&edition=full","pubTime":"2026-07-23 17:52","pubTimestamp":1784800347,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金陵药业披露，截至2026年7月20日公司股东户数为4.18万户，较7月10日增加1256.0户，增幅为3.1%。在化学制药行业个股中，金陵药业股东户数高于行业平均水平，截至7月20日，化学制药行业平均股东户数为3.58万户。从股价来看，2026年7月10日至2026年7月20日，金陵药业区间涨幅为2.28%，在此期间股东户数增加1256.0户，增幅为3.1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300036662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","000919","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653713669","title":"金陵药业：截至2026年7月20日，公司股东人数为41,764","url":"https://stock-news.laohu8.com/highlight/detail?id=2653713669","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653713669?lang=zh_cn&edition=full","pubTime":"2026-07-23 11:42","pubTimestamp":1784778131,"startTime":"0","endTime":"0","summary":"证券之星消息，金陵药业(000919)07月22日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截至7月20日公司股东人数是多少？金陵药业回复：投资者，您好！截至2026年7月20日，公司股东人数为41,764，感谢您对公司的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300019828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","000919","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653248569","title":"股市必读：金陵药业（000919）7月20日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2653248569","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653248569?lang=zh_cn&edition=full","pubTime":"2026-07-21 02:09","pubTimestamp":1784570950,"startTime":"0","endTime":"0","summary":"截至2026年7月20日收盘，金陵药业报收于6.27元，上涨0.0%，换手率2.4%，成交量14.95万手，成交额9372.9万元。董秘最新回复投资者： 你好，传言公司要花几十亿收购一家制药企业？有关公司信息请以公司在法定信息披露媒体发布的公告为准。交易信息汇总资金流向7月20日主力资金净流出95.44万元，占总成交额0.0%；游资资金净流出72.39万元，占总成交额0.0%；散户资金净流入167.83万元，占总成交额0.0%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100001601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000919","BK0096","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789754519703,"stockEarnings":[{"period":"1week","weight":-0.0015},{"period":"1month","weight":-0.0638},{"period":"3month","weight":0.059},{"period":"6month","weight":-0.0752},{"period":"1year","weight":-0.0606},{"period":"ytd","weight":-0.1741}],"compareEarnings":[{"period":"1week","weight":0.0061},{"period":"1month","weight":0.0045},{"period":"3month","weight":-0.0437},{"period":"6month","weight":-0.0114},{"period":"1year","weight":0.0209},{"period":"ytd","weight":-0.0144}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金陵药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"39042人(较上一季度减少3.12%)","perCapita":"15924股","listingDate":"1999-11-18","address":"江苏省南京市栖霞区经济技术开发区新港大道58号","registeredCapital":"62192万元","survey":" 金陵药业股份有限公司的主营业务是药品与医疗器械制造、医康养护服务。公司的主要产品是脉络宁注射液、脉络宁口服液、琥珀酸亚铁片、琥珀酸亚铁缓释片、香菇多糖注射液、吸收性明胶海绵、医疗服务、康养护服务。","listedPrice":8.4},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金陵药业(000919)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金陵药业(000919)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金陵药业,000919,金陵药业股票,金陵药业股票老虎,金陵药业股票老虎国际,金陵药业行情,金陵药业股票行情,金陵药业股价,金陵药业股市,金陵药业股票价格,金陵药业股票交易,金陵药业股票购买,金陵药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金陵药业(000919)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金陵药业(000919)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}